Alicia Jenkins

Professor Alicia Jenkins is a leading endocrinologist at the Baker Institute, specializing in diabetes and vascular medicine. She co-leads the Diabetes Program and directs a biomarker laboratory focused on diabetes complications, with over 450 publications and an H-index of 62.

• MBBS, MD (University of Melbourne)
• FRACP, FRCP

Her research spans:

• Prediction and prevention of diabetes complications
• Cardiovascular disease mechanisms
• Healthcare technology innovation
• Indigenous Australian eye care
• Insulin resistance in type 1 diabetes

Recent work includes clinical trials on metformin (REMOVAL), fenofibrate (FIELD), and colchicine, alongside developing free online calculators for retinopathy risk and insulin resistance. Her team collaborates globally with DCCT/EDIC, Finn Diane, and Hong Kong Diabetes Registry.

Scientific accolades include the Australian Diabetes Society Kellion Award (2019), NHMRC Academic Excellence Award (2019), and leadership roles in the Australian CardioVascular Alliance and International Diabetes Federation.

She mentors over 100 researchers, serves on grant panels, and advocates for equitable healthcare access through humanitarian organizations like Insulin for Life.